Although lung cancer is traditionally thought of as a “smoker’s disease,” a surprising 15-20% of newly diagnosed lung cancers occur in people who have never smoked, many of whom are in their 40s or 50s.
Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The